Chemours (CC)

• Market cap: $1.82B
• 1 day: 0.08%
• 5 days: 3.48%
• 1 month: -10.56%
• 3 months: 8.45%
• 6 months: -32.16%
• Year to date: -27.05%
• 1 year: -33.24%
• 5 years: -40.77%
• 10 years: 9.82%
• Sector: Materials
• Industry: Specialty Chemicals

About: The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Employees: 6,000

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

12% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 113

7.95% more ownership

Funds ownership: 84.32% [Q4 2024] → 92.28% (+7.95%) [Q1 2025]

9% more call options, than puts

Call options by funds: $20.2M | Put options by funds: $18.5M

5% less funds holding

Funds holding: 436 [Q4 2024] → 414 (-22) [Q1 2025]

12% less capital invested

Capital invested by funds: $2.13B [Q4 2024] → $1.87B (-$262M) [Q1 2025]

17% less first-time investments, than exits

New positions opened: 62 | Existing positions closed: 75

40% less funds holding in top 10

Funds holding in top 10: 5 [Q4 2024] → 3 (-2) [Q1 2025]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $13 7% upside
• Avg. target: $14.60 20% upside
• High target: $16 31% upside

5 analyst ratings

• positive: 2 40%
• neutral: 3 60%
• negative: 0 0%

Mizuho John Roberts	31% upside $16	Outperform Maintained	15 Jul 2025
RBC Capital Arun Viswanathan	23% upside $15	Outperform Maintained	3 Jul 2025
Barclays Michael Leithead	7% upside $13	Equal-Weight Maintained	28 May 2025
Goldman Sachs Duffy Fischer	15% upside $14	Neutral Maintained	14 May 2025
Morgan Stanley Vincent Andrews	23% upside $15	Equal-Weight Maintained	12 May 2025